Bruce McCreedy, PhD

Senior Vice President, Immuno-Oncology

Bruce joined Precision from NexImmune, an immunotherapy-focused company, where he served as Chief Development Officer and Executive Vice President of Research and Development. Before joining NexImmune, Dr. McCreedy served in leadership functions at Roche, LabCorp, Triangle Pharmaceuticals (Gilead), Metabolon, and Fulcrum Pharma. When he isn’t focused on developing drugs to treat serious and chronic diseases, Dr. McCreedy enjoys moonlighting as an amateur musician, and is an avid fisherman. He received his PhD in Microbiology and Immunology from Wake Forest University and has published his research extensively in the field of immunotherapy.